PD-1 receptor — Drug Target

All drugs that target PD-1 receptor — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Monoclonal antibody; PD-1 inhibitor

Marketed (1)

• Keytruda · Merck & Co. · Monoclonal antibody; PD-1 inhibitor · Oncology
  Pembrolizumab blocks PD-1 receptor, releasing immune inhibition and enhancing anti-tumor T-cell response.